Effects of ITPA and IFNL4 polymorphism during simeprevir, peg-interferon, and ribavirin combination and sofosbuvir and ribavirin combination treatment for chronic hepatitis C (1) Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C (2) ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C

k7554_1

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k7554_1.pdf

https://hiroshima.repo.nii.ac.jp/record/2004018/files/k7554_1.pdf

ファイル	ライセンス
k7554_1.pdf (161.5 kB) sha256 b721e423a5c022b2be363e31c50e06136ff9ba9ad66f0cd30d420fdcb6ff7c32

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays